Gene Biotherapeutics Inc (CRXM)
0.00
USD |
OTCM |
May 17, 16:00
Gene Biotherapeutics Total Liabilities (Quarterly): 4.092M for March 31, 2017
Total Liabilities (Quarterly) Chart
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| December 31, 2020 | 5.135M |
| September 30, 2020 | 5.054M |
| June 30, 2020 | 5.019M |
| March 31, 2020 | 5.148M |
| December 31, 2019 | 4.885M |
| March 31, 2017 | 4.319M |
| December 31, 2016 | 4.400M |
| September 30, 2016 | 4.293M |
| June 30, 2016 | 4.574M |
| March 31, 2016 | 4.077M |
| December 31, 2015 | 3.832M |
| September 30, 2015 | 3.408M |
| June 30, 2015 | 3.043M |
| March 31, 2015 | 2.724M |
| December 31, 2014 | 2.428M |
| September 30, 2014 | 2.319M |
| June 30, 2014 | 2.307M |
| March 31, 2014 | 2.258M |
| December 31, 2013 | 1.601M |
| September 30, 2013 | 1.179M |
| June 30, 2013 | 1.228M |
| March 31, 2013 | 1.252M |
| December 31, 2012 | 1.443M |
| September 30, 2012 | 1.297M |
| June 30, 2012 | 1.144M |
| Date | Value |
|---|---|
| March 31, 2012 | 1.796M |
| December 31, 2011 | 1.418M |
| September 30, 2011 | 1.442M |
| June 30, 2011 | 1.809M |
| March 31, 2011 | 1.903M |
| December 31, 2010 | 2.084M |
| September 30, 2010 | 5.051M |
| June 30, 2010 | 4.355M |
| March 31, 2010 | 6.477M |
| December 31, 2009 | 7.630M |
| September 30, 2009 | 24.47M |
| June 30, 2009 | 38.22M |
| March 31, 2009 | 28.82M |
| December 31, 2008 | 11.05M |
| September 30, 2008 | 7.576M |
| June 30, 2008 | 9.699M |
| March 31, 2008 | 8.394M |
| December 31, 2007 | 8.497M |
| September 30, 2007 | 3.089M |
| June 30, 2007 | 3.274M |
| March 31, 2007 | 1.916M |
| December 31, 2006 | 2.964M |
| September 30, 2006 | 1.714M |
| June 30, 2006 | 1.346M |
| March 31, 2006 | 1.463M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
4.885M
Minimum
Dec 2019
5.148M
Maximum
Mar 2020
5.048M
Average
5.054M
Median
Sep 2020
Total Liabilities (Quarterly) Benchmarks
| AIM ImmunoTech Inc | 9.147M |
| Perspective Therapeutics Inc | 48.40M |
| Protalix BioTherapeutics Inc | 60.04M |
| Electromed Inc | 6.357M |
| Armata Pharmaceuticals Inc | 176.87M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 0.3739M |
| Shareholders Equity (Quarterly) | -3.718M |